Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 111Neoplasms 8Neoplasm Metastasis 6Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 4Arthralgia 4Advanced Breast Cancer 4Osteoporosis 2Multiple Endocrine Neoplasia Type 1 2Breast Neoplasms, Male 2Breast Cancer Metastatic 2Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Seizures 1Recurrence 1Quality of Life 1Patient Compliance 1Pain 1Ovarian Neoplasms 1Obesity 1Lethal Congenital Contracture Syndrome 2 1Joint Diseases 1Invasive Breast Cancer 1Hypogonadism 1Granulosa Cell Ovarian Cancer 1Fractures, Bone 1Erectile Dysfunction 1Epilepsy 1Bone Diseases, Metabolic 1Bone Density 1

Interventions

Sildenafil Citrate 2udenafil 1methyl 3-mercaptopropionimidate 1bicalutamide 1alpha-Tocopherol 1Vitamin E 1Tamoxifen 1Tadalafil 1Tacrolimus 1Restraint, Physical 1Psychiatric Rehabilitation 1Preservation, Biological 1Pentoxifylline 1Menogaril 1Long-Term Synaptic Depression 1Intraoperative Neurophysiological Monitoring 1GPI 1485 1Exercise 1Erythropoietin 1Early Intervention, Educational 1Dutasteride 1Cell- and Tissue-Based Therapy 1Atorvastatin 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Erectile Dysfunction × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡